The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Cmea Ventures Vii (parallel) Lp since 2014.
The trader's CIK number is 1405972.
At the time of the last reporting, Cmea Ventures Vii (parallel) Lp was the 10% Owner of Auspex Pharmaceuticals, Inc.. (stock ticker symbol ASPX).
Also see all insider trading activities at Auspex Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | ASPX | 0 | $0 | 303,344 | $18,602,300 | 0 | $0 |
| 2014 | ASPX | 105,561 | $1,266,732 | 352,109 | $13,561,701 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | ARDX | 0 | $0 | 470,000 | $11,927,900 | 0 | $0 |
| 2014 | ARDX | 316,826 | $4,435,564 | 0 | $0 | 0 | $0 |
1. Auspex Pharmaceuticals, Inc. (ASPX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-01-08 | ASPX | Sale | 3,344 | 49.13 | 164,287 |
| 2015-02-12 | ASPX | Sale | 80,834 | 63.48 | 5,131,423 |
| 2015-02-13 | ASPX | Sale | 41,833 | 62.98 | 2,634,767 |
| 2015-02-09 | ASPX | Sale | 9,854 | 59.00 | 581,386 |
| 2015-02-10 | ASPX | Sale | 21,200 | 60.05 | 1,273,060 |
| 2015-02-11 | ASPX | Sale | 53,100 | 61.84 | 3,283,704 |
| 2015-02-06 | ASPX | Sale | 30,279 | 59.48 | 1,800,994 |
| 2015-02-05 | ASPX | Sale | 12,900 | 59.51 | 767,679 |
| 2015-02-04 | ASPX | Sale | 50,000 | 59.30 | 2,965,000 |
| 2014-12-18 | ASPX | Sale | 195,000 | 50.14 | 9,777,300 |
| 2014-10-29 | ASPX | Sale | 11,170 | 27.02 | 301,846 |
| 2014-10-30 | ASPX | Sale | 7,830 | 27.33 | 213,962 |
| 2014-10-27 | ASPX | Sale | 3,500 | 27.11 | 94,899 |
| 2014-10-28 | ASPX | Sale | 11,000 | 26.99 | 296,901 |
| 2014-10-23 | ASPX | Sale | 5,600 | 26.73 | 149,716 |
| 2014-10-24 | ASPX | Sale | 10,900 | 27.09 | 295,237 |
| 2014-10-06 | ASPX | Sale | 7,109 | 23.45 | 166,670 |
| 2014-09-04 | ASPX | Sale | 16,700 | 24.05 | 401,668 |
| 2014-09-05 | ASPX | Sale | 8,900 | 23.50 | 209,141 |
| 2014-09-02 | ASPX | Sale | 10,200 | 23.07 | 235,303 |
| 2014-09-03 | ASPX | Sale | 12,500 | 23.09 | 288,675 |
| 2014-08-29 | ASPX | Sale | 8,700 | 22.59 | 196,550 |
| 2014-08-28 | ASPX | Sale | 12,200 | 22.24 | 271,352 |
| 2014-08-27 | ASPX | Sale | 17,400 | 21.88 | 380,659 |
| 2014-08-26 | ASPX | Sale | 6,300 | 21.35 | 134,517 |
| 2014-08-25 | ASPX | Sale | 5,400 | 20.81 | 112,357 |
| 2014-08-22 | ASPX | Sale | 1,700 | 20.56 | 34,948 |
| 2014-02-10 | ASPX | Buy | 105,561 | 12.00 | 1,266,732 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-01-30 | ARDX | Sale | 170,000 | 27.37 | 4,652,900 |
| 2015-01-08 | ARDX | Sale | 300,000 | 24.25 | 7,275,000 |
| 2014-06-24 | ARDX | Buy | 316,826 | 14.00 | 4,435,564 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cmea Ventures Vii (parallel) Lp (10% Owner of Auspex Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.